Product Name

  • Name

    Mebendazole

  • EINECS 250-635-4
  • CAS No. 31431-39-7
  • Article Data10
  • CAS DataBase
  • Density 1.388 g/cm3
  • Solubility 35.4mg/L(25 oC)
  • Melting Point 288.5 °C
  • Formula C16H13N3O3
  • Boiling Point 436.98°C (rough estimate)
  • Molecular Weight 295.298
  • Flash Point
  • Transport Information UN 2811
  • Appearance white to yellowish powder
  • Safety 36
  • Risk Codes 22
  • Molecular Structure Molecular Structure of 31431-39-7 (Mebendazole)
  • Hazard Symbols HarmfulXn
  • Synonyms Methyl 5-benzoyl-2-benzimidazolecarbamate;2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester;Sufil;R 17635;Equivurm Plus;MBDZ;Methyl 5-benzoyl benzimidazole-2-carbamate;Versid;(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester;Mebex;Verpanyl;Mebendazole (JAN/USP);2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI);Mebutar;5-Benzoyl-2-benzimidazolecarbamic acid methyl ester;Telmin;Vermox (TN);R 17,635;Bantenol;Telluryl compoundsTelmin;Vermox;R 17, 635;Lomper;Pantelmin;Methyl 5-benzoyl-2-benzimidazolylcarbamate;
  • PSA 84.08000
  • LogP 3.04520

Synthetic route

4-benzoylbenzene-1,2-diamine
39070-63-8

4-benzoylbenzene-1,2-diamine

O-methyl-N-(methoxycarbonyl)-isourea
40943-37-1

O-methyl-N-(methoxycarbonyl)-isourea

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
With acetic acid In toluene95%
With hydrogenchloride In chloroform Cooling with ice; Reflux;
(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone
52329-60-9

(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone

methyl chloroformate
79-22-1

methyl chloroformate

A

isomebendazole
104663-13-0

isomebendazole

B

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
With pyridine Ambient temperature; Yield given. Yields of byproduct given;
With pyridine Ambient temperature;A 0.5 g
B 0.1 g
(3,4-diaminophenyl)phenylmethanone hydrochloride
57070-71-0

(3,4-diaminophenyl)phenylmethanone hydrochloride

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 6 g / sodium hydroxide / H2O / 12 h / Heating
2: 0.1 g / pyridine / Ambient temperature
View Scheme
[Ru(η6-p-cymene)Cl2(mebendazole)]

[Ru(η6-p-cymene)Cl2(mebendazole)]

C26H27Cl2N3O3Ru

C26H27Cl2N3O3Ru

dimethyl sulfoxide
67-68-5

dimethyl sulfoxide

A

[Ru(η6-p-cymene)(dmso)Cl2]
115543-07-2

[Ru(η6-p-cymene)(dmso)Cl2]

B

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
In chloroform
3,4-dinitrobenzoic acid
528-45-0

3,4-dinitrobenzoic acid

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: thionyl chloride / N,N-dimethyl-formamide / 0 °C
2: aluminum (III) chloride / dichloromethane / 3 h / Reflux; Inert atmosphere
3: palladium 10% on activated carbon; hydrogen / methanol / 24 h / 20 °C
4: hydrogenchloride / chloroform / Cooling with ice; Reflux
View Scheme
3,4-dinitrobenzoyl chloride
24376-18-9

3,4-dinitrobenzoyl chloride

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: aluminum (III) chloride / dichloromethane / 3 h / Reflux; Inert atmosphere
2: palladium 10% on activated carbon; hydrogen / methanol / 24 h / 20 °C
3: hydrogenchloride / chloroform / Cooling with ice; Reflux
View Scheme
3,4-dinitrobenzophenone
33609-48-2

3,4-dinitrobenzophenone

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: palladium 10% on activated carbon; hydrogen / methanol / 24 h / 20 °C
2: hydrogenchloride / chloroform / Cooling with ice; Reflux
View Scheme
methyl N-(1-methylthio-1-iminomethyl)-carbamate
39259-32-0

methyl N-(1-methylthio-1-iminomethyl)-carbamate

4-benzoylbenzene-1,2-diamine
39070-63-8

4-benzoylbenzene-1,2-diamine

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
With acetic acid In methanol at 75 - 80℃;
para-chlorotoluene
106-43-4

para-chlorotoluene

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: nitric acid / 70 °C
2: nitric acid / 50 °C
3: thionyl chloride / N,N-dimethyl-formamide / 75 - 80 °C
4: ammonia / 130 - 135 °C / 4500.45 - 5250.53 Torr
5: sulfur; sodium hydroxide / methanol / 78 - 80 °C
6: acetic acid / methanol / 75 - 80 °C
View Scheme
para-chlorobenzoic acid
74-11-3

para-chlorobenzoic acid

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: nitric acid / 50 °C
2: thionyl chloride / N,N-dimethyl-formamide / 75 - 80 °C
3: ammonia / 130 - 135 °C / 4500.45 - 5250.53 Torr
4: sulfur; sodium hydroxide / methanol / 78 - 80 °C
5: acetic acid / methanol / 75 - 80 °C
View Scheme
4-chloro-3-nitrobenzoate
96-99-1

4-chloro-3-nitrobenzoate

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: thionyl chloride / N,N-dimethyl-formamide / 75 - 80 °C
2: ammonia / 130 - 135 °C / 4500.45 - 5250.53 Torr
3: sulfur; sodium hydroxide / methanol / 78 - 80 °C
4: acetic acid / methanol / 75 - 80 °C
View Scheme
4-chloro-3-nitrobenzophenone
56107-02-9

4-chloro-3-nitrobenzophenone

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: ammonia / 130 - 135 °C / 4500.45 - 5250.53 Torr
2: sulfur; sodium hydroxide / methanol / 78 - 80 °C
3: acetic acid / methanol / 75 - 80 °C
View Scheme
methyl-N-cyano carbamate
21729-98-6

methyl-N-cyano carbamate

4-benzoylbenzene-1,2-diamine
39070-63-8

4-benzoylbenzene-1,2-diamine

mebendazole
31431-39-7

mebendazole

Conditions
ConditionsYield
With hydrogenchloride In water; acetone at 97℃; for 5.16h; Temperature;
mebendazole
31431-39-7

mebendazole

(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone
52329-60-9

(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone

Conditions
ConditionsYield
With potassium hydroxide In methanol for 24h; Heating;98%
With potassium hydroxide In methanol for 96h; Heating;98%
With potassium hydroxide In methanol for 24h; Heating;89%
With sulfuric acid for 3h; Heating;81%
With sodium hydroxide In water; isopropyl alcohol for 8h; Heating;27 g
propionic acid
802294-64-0

propionic acid

mebendazole
31431-39-7

mebendazole

mebendazole propanoic acid

mebendazole propanoic acid

Conditions
ConditionsYield
at 120℃;89%
mebendazole
31431-39-7

mebendazole

Methyl 5-(α-hydroxyphenylmethyl)-1H-benzimidazole-2-carbamate
60254-95-7

Methyl 5-(α-hydroxyphenylmethyl)-1H-benzimidazole-2-carbamate

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol Heating;87%
mebendazole
31431-39-7

mebendazole

butyric acid
107-92-6

butyric acid

mebendazole butanoic acid

mebendazole butanoic acid

Conditions
ConditionsYield
at 120℃;87%
trifluoroacetic acid
76-05-1

trifluoroacetic acid

mebendazole
31431-39-7

mebendazole

mebendazole trifluoroacetate

mebendazole trifluoroacetate

Conditions
ConditionsYield
In ethanol82%
acetic acid
64-19-7

acetic acid

mebendazole
31431-39-7

mebendazole

mebendazole acetic acid

mebendazole acetic acid

Conditions
ConditionsYield
at 100℃;73%
formic acid
64-18-6

formic acid

mebendazole
31431-39-7

mebendazole

mebendazole formate

mebendazole formate

Conditions
ConditionsYield
at 100℃;65%
oxetan-3-ol
7748-36-9

oxetan-3-ol

mebendazole
31431-39-7

mebendazole

oxetan-3-yl N-(5-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate

oxetan-3-yl N-(5-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 60 - 70℃; for 0.333333h; Microwave irradiation;53%
With triethylamine In N,N-dimethyl-formamide for 0.25h; Microwave irradiation;
ethanolamine
141-43-5

ethanolamine

mebendazole
31431-39-7

mebendazole

A

(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone
52329-60-9

(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone

B

1-(5-benzoylbenzimidazol-2-yl)-3-(2-hydroxyethyl)urea
89597-80-8

1-(5-benzoylbenzimidazol-2-yl)-3-(2-hydroxyethyl)urea

Conditions
ConditionsYield
at 100℃; for 72h;A 52%
B 24%
mebendazole
31431-39-7

mebendazole

valeric acid
109-52-4

valeric acid

mebendazole valeric acid

mebendazole valeric acid

Conditions
ConditionsYield
at 120℃;52%
1-methyl-piperazine
109-01-3

1-methyl-piperazine

mebendazole
31431-39-7

mebendazole

A

(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone
52329-60-9

(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone

B

1-(5-benzoylbenzimidazol-2-yl)-3-(4-methylpiperazino)urea
89597-79-5

1-(5-benzoylbenzimidazol-2-yl)-3-(4-methylpiperazino)urea

Conditions
ConditionsYield
for 6h; Heating;A 37%
B 46%
2-(2-Aminoethylamino)ethanol
111-41-1

2-(2-Aminoethylamino)ethanol

mebendazole
31431-39-7

mebendazole

A

(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone
52329-60-9

(2-amino-1H-benzimidazol-5-yl)(phenyl)methanone

B

1-(5-benzoylbenzimidazol-2-yl)-3-<2-<(2-hydroxyethyl)amino>ethyl>urea
89597-81-9

1-(5-benzoylbenzimidazol-2-yl)-3-<2-<(2-hydroxyethyl)amino>ethyl>urea

Conditions
ConditionsYield
at 100℃; for 2h;A n/a
B 39%
1-(tert-butyl) 5-(chloromethyl) (tert-butoxycarbonyl)-L-glutamate

1-(tert-butyl) 5-(chloromethyl) (tert-butoxycarbonyl)-L-glutamate

mebendazole
31431-39-7

mebendazole

5-((5-benzoyl-2-((methoxycarbonyl)amino)-1H-benzo[d]imidazol-1-yl)methyl) 1-(tert-butyl) (tert-butoxycarbonyl)-L-glutamate

5-((5-benzoyl-2-((methoxycarbonyl)amino)-1H-benzo[d]imidazol-1-yl)methyl) 1-(tert-butyl) (tert-butoxycarbonyl)-L-glutamate

Conditions
ConditionsYield
Stage #1: mebendazole With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 1h; Schlenk technique; Inert atmosphere;
Stage #2: 1-(tert-butyl) 5-(chloromethyl) (tert-butoxycarbonyl)-L-glutamate In N,N-dimethyl-formamide at 20℃; for 16h;
32%
N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

mebendazole
31431-39-7

mebendazole

1-(5-benzoyl benzimidazol-2-yl)-3, 3-dimethylurea
89597-82-0

1-(5-benzoyl benzimidazol-2-yl)-3, 3-dimethylurea

Conditions
ConditionsYield
With N-[2-(diethylamino)ethyl]hydrazine at 100℃; for 72h;26%
chloromethyl (((2R,3R,4S,5R,6R)-3,4,5,6-tetrakis((trimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)methyl) carbonate

chloromethyl (((2R,3R,4S,5R,6R)-3,4,5,6-tetrakis((trimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)methyl) carbonate

mebendazole
31431-39-7

mebendazole

methyl (5-benzoyl-1-((((((2R,3R,4S,5R,6R)-3,4,5,6-tetrakis-((trimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)methoxy)-carbonyl)oxy)methyl)-1H-benzo[d]imidazol-2-yl)carbamate

methyl (5-benzoyl-1-((((((2R,3R,4S,5R,6R)-3,4,5,6-tetrakis-((trimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)methoxy)-carbonyl)oxy)methyl)-1H-benzo[d]imidazol-2-yl)carbamate

Conditions
ConditionsYield
Stage #1: mebendazole With potassium tert-butylate In dimethyl sulfoxide at 20℃; for 0.25h; Sonication;
Stage #2: chloromethyl (((2R,3R,4S,5R,6R)-3,4,5,6-tetrakis-((trimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)methyl)carbonate In dimethyl sulfoxide at 20℃; for 1h;
25%
4-chloromethyl-5-methyl-1,3-dioxol-2-one
80841-78-7

4-chloromethyl-5-methyl-1,3-dioxol-2-one

mebendazole
31431-39-7

mebendazole

methyl (5-benzoyl-1H-benzo[d]imidazol-2-yl)((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)carbamate

methyl (5-benzoyl-1H-benzo[d]imidazol-2-yl)((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)carbamate

Conditions
ConditionsYield
Stage #1: mebendazole With potassium tert-butylate In dimethyl sulfoxide at 20℃; for 0.25h; Sonication;
Stage #2: 4-chloromethyl-5-methyl-1,3-dioxol-2-one In dimethyl sulfoxide at 20℃; for 1h;
23%
mebendazole
31431-39-7

mebendazole

hexanoic acid
142-62-1

hexanoic acid

mebendazole hexanoic acid

mebendazole hexanoic acid

Conditions
ConditionsYield
at 120℃;6%
methyl chloroformate
79-22-1

methyl chloroformate

mebendazole
31431-39-7

mebendazole

A

6-Benzoyl-2-methoxycarbonylamino-benzoimidazole-1-carboxylic acid methyl ester
104663-14-1

6-Benzoyl-2-methoxycarbonylamino-benzoimidazole-1-carboxylic acid methyl ester

B

5-Benzoyl-2-methoxycarbonylamino-benzoimidazole-1-carboxylic acid methyl ester
104662-93-3

5-Benzoyl-2-methoxycarbonylamino-benzoimidazole-1-carboxylic acid methyl ester

C

5-Benzoyl-2-oxo-benzoimidazole-1,3-dicarboxylic acid dimethyl ester
104663-32-3

5-Benzoyl-2-oxo-benzoimidazole-1,3-dicarboxylic acid dimethyl ester

Conditions
ConditionsYield
With alkali
mebendazole
31431-39-7

mebendazole

2,4-dimethylpyrimido<1,2-a>benzimidazol-7-ylphenylmethanone

2,4-dimethylpyrimido<1,2-a>benzimidazol-7-ylphenylmethanone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 81 percent / 70percent H2SO4 / 3 h / Heating
2: 82 percent / 3 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: 89 percent / aq. KOH / methanol / 24 h / Heating
2: acetic acid / 6 h / Heating
View Scheme
mebendazole
31431-39-7

mebendazole

7-benzoyl-4-phenyl-1,3,5-triazino<1,2-a>benzimidazole-2(1H)-thione

7-benzoyl-4-phenyl-1,3,5-triazino<1,2-a>benzimidazole-2(1H)-thione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 81 percent / 70percent H2SO4 / 3 h / Heating
2: acetone / 8 h / Heating
View Scheme
mebendazole
31431-39-7

mebendazole

2,4-dimethylpyrimido<1,2-a>benzimidazol-8-ylphenylmethanone

2,4-dimethylpyrimido<1,2-a>benzimidazol-8-ylphenylmethanone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 89 percent / aq. KOH / methanol / 24 h / Heating
2: acetic acid / 6 h / Heating
View Scheme
mebendazole
31431-39-7

mebendazole

7-benzoyl-4-hydroxyl-2-methylpyrimido<1,2-a>benzimidazile

7-benzoyl-4-hydroxyl-2-methylpyrimido<1,2-a>benzimidazile

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 89 percent / aq. KOH / methanol / 24 h / Heating
2: acetic acid / 8 h / Heating
View Scheme
mebendazole
31431-39-7

mebendazole

8-benzoyl-4-hydroxyl-2-methylpyrimido<1,2-a>benzimidazile

8-benzoyl-4-hydroxyl-2-methylpyrimido<1,2-a>benzimidazile

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 89 percent / aq. KOH / methanol / 24 h / Heating
2: acetic acid / 8 h / Heating
View Scheme
mebendazole
31431-39-7

mebendazole

4-amino-7-benzoyl-3-cyanopyrimido<1,2-a>benzimidazole

4-amino-7-benzoyl-3-cyanopyrimido<1,2-a>benzimidazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 89 percent / aq. KOH / methanol / 24 h / Heating
2: acetic acid / 5 h / Heating
View Scheme
mebendazole
31431-39-7

mebendazole

4-amino-8-benzoyl-3-cyanopyrimido<1,2-a>benzimidazole

4-amino-8-benzoyl-3-cyanopyrimido<1,2-a>benzimidazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 89 percent / aq. KOH / methanol / 24 h / Heating
2: acetic acid / 5 h / Heating
View Scheme

Mebendazole Chemical Properties

Molecular Structure of Mebendazole (CAS NO.31431-39-7):

IUPAC Name: methyl N-(6-Benzoyl-1H-benzimidazol-2-yl)carbamate
Canonical SMILES: COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3
InChI: InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)
InChIKey: OPXLLQIJSORQAM-UHFFFAOYSA-N
Molecular Formula: C16H13N3O3
Molar mass: 295.2927 g/mol
Index of Refraction: 1.702
Molar Refractivity: 82.43 cm3
Molar Volume: 212.6 cm3
Surface Tension: 66.7 dyne/cm
Density: 1.388 g/cm3
Melting point: 288.5 °C
storage temp: 0-6 °C
Water solubility: insoluble
Appearance: White Amorphous Powder
Product Categories: Intermediates & Fine Chemicals; Miscellaneous Natural Products; Miscellaneous Enzyme; Pharmaceuticals

Mebendazole Uses

 Mebendazole (CAS NO.31431-39-7) is used to treat infestations by worms including pinworms, roundworms, tapeworms, hookworms, and whipworms.

Mebendazole Production

Take o-dichlorobenzene and benzoyl chloride as raw materials,the product can be derived by condensation, amination, cyclization.

Mebendazole Toxicity Data With Reference

cat LD50 oral > 640mg/kg (640mg/kg)   Toxicology and Applied Pharmacology. Vol. 24, Pg. 371, 1973.
chicken LD50 unreported > 40mg/kg (40mg/kg)   United States Patent Document. Vol. #3657267,
dog LD intramuscular > 2gm/kg (2000mg/kg)   Drugs in Japan Vol. -, Pg. 1207, 1990.
dog LD50 oral 1280mg/kg (1280mg/kg)   Drugs in Japan Vol. -, Pg. 1207, 1990.
domestic animals - goat/sheep LD50 oral > 80mg/kg (80mg/kg)   United States Patent Document. Vol. #3657267,
guinea pig LD50 oral > 1280mg/kg (1280mg/kg)   Toxicology and Applied Pharmacology. Vol. 24, Pg. 371, 1973.
mouse LD50 intraperitoneal 712mg/kg (712mg/kg)   Meditsinskaya Parazitologiya i Parazitarnye Bolezni. Medical Parasitology and Parasitic Diseases. Vol. 48(4), Pg. 29, 1979.
mouse LD50 oral 620mg/kg (620mg/kg)   Meditsinskaya Parazitologiya i Parazitarnye Bolezni. Medical Parasitology and Parasitic Diseases. Vol. 47(6), Pg. 48, 1978.
rabbit LD50 oral > 640mg/kg (640mg/kg)   Toxicology and Applied Pharmacology. Vol. 24, Pg. 371, 1973.
rat LD50 intramuscular 350mg/kg (350mg/kg)   Drugs in Japan Vol. -, Pg. 1207, 1990.
rat LD50 oral 714mg/kg (714mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 735, 1988.

Mebendazole Consensus Reports

EPA Genetic Toxicology Program.

Mebendazole Safety Profile

Moderately toxic by ingestion and intraperitoneal routes. Human mutation data reported. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
Safety Information of Mebendazole (CAS NO.31431-39-7):
Hazard Codes: Xn
Risk Statements:
22:  Harmful if swallowed 
Safety Statements:
36:  Wear suitable protective clothing
RIDADR: UN 2811
WGK Germany: 3
RTECS: EY8600000

Mebendazole Specification

 Mebendazole (CAS NO.31431-39-7), its Synonyms are (5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester ; 2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester ; 5-Benzoyl-2-benzimidazolecarbamic acid methyl ester ; Bantenol ; Besantin ; Mebendazolum ; Methyl 5-benzoyl-2-benzimidazolecarbamate ; Methyl 5-benzoyl-2-benzimidazolylcarbamate ; Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate ; N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle ; N-2 (5-Benzoyl-benzimidazole) carbamate de methyle .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View